Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman Sells 14,500 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 14,500 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $12.00, for a total value of $174,000.00. Following the sale, the chief financial officer now owns 264,429 shares of the company’s stock, valued at approximately $3,173,148. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Robert Thomas Freeman also recently made the following trade(s):

• On Wednesday, September 11th, Robert Thomas Freeman sold 8,561 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.01, for a total value of $85,695.61.
• On Wednesday, September 4th, Robert Thomas Freeman sold 1,650 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.00, for a total value of $16,500.00.
• On Friday, July 19th, Robert Thomas Freeman sold 38,858 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.01, for a total transaction of $388,968.58.
• On Wednesday, July 17th, Robert Thomas Freeman sold 22,100 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.00, for a total transaction of $221,000.00.

Alignment Healthcare Stock Up 2.7 %

Shares of NASDAQ ALHC opened at $11.89 on Monday. The company has a market cap of $2.27 billion, a price-to-earnings ratio of -14.15 and a beta of 1.43. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.70. Alignment Healthcare, Inc. has a 12 month low of $4.46 and a 12 month high of $12.36. The stock has a 50-day moving average price of $9.15 and a two-hundred day moving average price of $7.29.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Thursday, August 1st. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.01. Alignment Healthcare had a negative net margin of 6.85% and a negative return on equity of 101.10%. The business had revenue of $681.29 million during the quarter, compared to analysts’ expectations of $637.66 million. During the same period in the prior year, the company earned ($0.15) EPS. The firm’s quarterly revenue was up 47.3% compared to the same quarter last year. As a group, analysts forecast that Alignment Healthcare, Inc. will post -0.67 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have issued reports on ALHC. Baird R W upgraded shares of Alignment Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. TD Cowen raised their price objective on Alignment Healthcare from $8.00 to $10.00 and gave the stock a “buy” rating in a research note on Tuesday, August 6th. Robert W. Baird upped their target price on Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a research report on Wednesday, August 14th. Stifel Nicolaus raised their price target on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “buy” rating in a research report on Friday, July 26th. Finally, Piper Sandler reiterated an “overweight” rating and set a $10.00 price objective (up from $8.00) on shares of Alignment Healthcare in a research note on Tuesday, August 6th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, six have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $9.83.

Institutional Investors Weigh In On Alignment Healthcare

Hedge funds have recently modified their holdings of the company. Victory Capital Management Inc. raised its position in Alignment Healthcare by 17.9% in the fourth quarter. Victory Capital Management Inc. now owns 12,935 shares of the company’s stock valued at $111,000 after purchasing an additional 1,962 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Alignment Healthcare by 1.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 751,309 shares of the company’s stock valued at $6,469,000 after buying an additional 10,123 shares during the last quarter. Jump Financial LLC acquired a new stake in Alignment Healthcare during the 4th quarter worth approximately $575,000. Aigen Investment Management LP grew its holdings in Alignment Healthcare by 18.5% during the 4th quarter. Aigen Investment Management LP now owns 19,764 shares of the company’s stock worth $170,000 after acquiring an additional 3,092 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC increased its position in Alignment Healthcare by 9.2% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 39,570 shares of the company’s stock valued at $196,000 after acquiring an additional 3,334 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.